Proteoglycans in the Control of Tumor Growth and Metastasis Formation

REFERENCES

• Joseph R., Bishop J.R., Schuksz M., Esko J. D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007; 446
   Web of Science ®Google Scholar
• Cattaruzza S., Perris R. Approaching the proteoglycome: molecular interactions of proteoglycans and their functional output. Macromol. Biosci. 2006; 6: 667–680
   PubMed Web of Science ®Google Scholar
• Oh E.S., Couchman J.R. Syndecans-2 and -4: close cousins, but not identical twins. Mol. Cells 2004; 17: 181–187
   PubMed Web of Science ®Google Scholar
• Simons M., Horowitz A. Syndecan-4-mediated signalling. Cell Signal. 2001; 13: 855–862
   PubMed Web of Science ®Google Scholar
• Tkachenko E., Rhodes J.M., Simons M. Syndecans new kids on signaling block. Circ Res. 2004; 96: 488–500
   Web of Science ®Google Scholar
• Zhang Y., Li J., Partovian C., Sellke F.W., Simons M. Syndecan-4 modulates basic fibroblast growth factor 2 signaling in vivo. Am. J. Physiol. Heart Circ. Physiol. 2003; 284: 2078–2082
   PubMedGoogle Scholar
• Fjeldstad K., Kolset S.O. Decreasing the metastatic potential in cancers: targeting the heparan sulfate proteoglycans. Curr. Drug Targets 2005; 6: 665–682
   PubMed Web of Science ®Google Scholar
• Ricciardelli C., Mayne K., Sykes P.J., Raymond W.A., McCaul K., Marshall V.R., Tilley W.D., Skinner J.M., Horsfall D.J. Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer. Clin. Cancer Res. 1997; 6: 983–992
   Google Scholar
• Leygue E., Snell L., Dotzlaw H., Troup S., Hiller-Hitchcock T., Murphy L.C., Roughley P.J., Watson P.H. Lumican and decorin are differentially expressed in human breast carcinoma. J. Pathol. 2000; 192: 313–320
   PubMed Web of Science ®Google Scholar
• Nara Y., Kato Y., Torii Y., Tsuji Y., Nakagaki S., Goto S., Isobe H., Nakashima N., Takeuchi J. Immunohistochemical localization of extracellular matrix components in human breast tumors with special reference to PG-M/versican. Histochem. J. 1997; 1: 21–30
   Google Scholar
• Labropoulou V.T., Theocharis A.D., Ravazoula P., Perimenis P., Hjerpe A., Karamanos N.K., Kalofonos H.P. Versican but not decorin accumulation is related to metastatic potential and neovascularization in testicular germ cell tumors. Histopathology 2006; 49: 582–593
   PubMed Web of Science ®Google Scholar
• Kodama J., Hasengaowa, Kusumoto T., Seki N., Matsuo T., Ojima Y., Nakamura K., Hongo A., Hiramatsu Y. Prognostic significance of stromal versican expression in human endometrial cancer. Ann. Oncol. 2007; 18: 269–274
   PubMed Web of Science ®Google Scholar
• Miquel-Serra L., Serra M., Hernández D., Domenzain C., Docampo M.J., Rabanal R.M., de Torres I., Wight T.N., Fabra A., Bassols A. V3 versican isoform expression has a dual role in human melanoma tumor growth and metastasis. Lab. Invest. 2006; 86: 889–901
   PubMed Web of Science ®Google Scholar
• Yee A.J., Akens M., Yang B.L., Finkelstein J., Zheng P.S., Deng Z., Yang B. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Res. 2007; 9: R47
   Google Scholar
• Ladányi A., Gallai M., Paku S., Nagy J.O., Dudás J., Tímár J., Kovalszky I. Expression of a decorin-like moleculein human melanoma. Pathol. Oncol. Res. 2001; 7: 260–266
   PubMedGoogle Scholar
• Blackhall F.H., Merry C.L., Davies E.J., Jayson G.C. Heparan sulfate proteoglycans and cancer. Br. J. Cancer 2001; 19: 1094–1098
   Google Scholar
• Sanderson R.D. Heparan sulfate proteoglycans in invasion and metastasis. Cell Dev. Biol. 2001; 12: 89–98
   Google Scholar
• Yang Y., Macleod V., Miao H.Q., Theus A., Zhan F., Shaughnessy J.D., Jr, Sawyer J., Li J.P., Zcharia E., Vlodavsky I., Sanderson R.D. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis. J. Biol. Chem. 2007; 282: 13326–13333
   PubMed Web of Science ®Google Scholar
• Stallcup W.B. The NG2 proteoglycan: past insights and future prospects. J. Neurocytol. 2002; 31: 423–435
   PubMedGoogle Scholar
• Lynch S.A., Bouchard B.N., Vijayasaradhi S., Yuasa H., Houghton A.N. Antigens of melanocytes and melanoma. Cancer Metast. Rev. 1991; 10: 141–150
   PubMed Web of Science ®Google Scholar
• Burg M.A., Grako K.A., Stallcup W.B. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells. J. Cell Physiol. 1998; 177: 299–312
   PubMed Web of Science ®Google Scholar
• Lin X.H., Dahlin-Huppe K., Stallcup W.B. Interaction of the NG2 proteoglycan with the actin cytoskeleton. J. Cell. Biochem. 1996; 63: 463–477
   PubMed Web of Science ®Google Scholar
• Fang X., Burg M.A., Barritt D., Dahlin-Huppe K., Nishiyama A., Stallcup W.B. Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. Mol. Biol. Cell 1999; 10: 3373–3387
   PubMed Web of Science ®Google Scholar
• Barritt D.S., Pearn M.T., Zisch A.H., Lee S.S., Javier R.T., Pasquale E.B., Stallcup W.B. The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2. J. Cell Biochem. 2000; 79: 213–224
   PubMed Web of Science ®Google Scholar
• Allen B.J., Rizvi S., Li Y., Tian Z., Ranson M. In vitro and preclinical targeted alpha therapy for melanoma, breast, prostate and colorectal cancers. Crit. Rev. Oncol. Hematol. 2001; 39: 139–146
   PubMed Web of Science ®Google Scholar
• Allen B.J., Rizvi S.M.A., Tian Z. Preclinical targeted alpha therapy for subcutaneous melanoma. Melanoma Res. 2001; 11: 175–182
   PubMed Web of Science ®Google Scholar
• Li Y., Wang J., Rizvi S.M.A., Jager M.J., Conway R.M., Billson F.A., Allen B.J., Madigan M.C. In vitro targeting of NG2 antigen by 213Bi-9.2.27 α-immunoconjugate induces cytotoxicity in human uveal melanoma cells. Invest. Ophthalmol. Vis. Sci. 2005; 46: 4365–4371
   PubMed Web of Science ®Google Scholar
• Bumol T.F., Wang Q.C., Reisfeld R.A., Kaplan N.O. Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth. Proc. Natl. Acad. Sci. 1983; 80: 529–533
   PubMed Web of Science ®Google Scholar